Register now!

Cushing’s Disease: Choices, Challenges and Complications
Diagnosis, Therapies and Challenging Complications in the Management of Cushing’s Disease

This webinar is free for CSEM members and $60 for non-members.

Join us for this online seminar on Cushing’s disease that will focus on new developments in diagnosis, treatment and management strategies.

For your convenience, we will be offering three date options — two in English and one in French.

Eastern Canada English
Tuesday, September 14, 2021
7:00 pm – 9:00 PM ET

Western Canada English
Tuesday, September 28, 2021
8:00 pm – 10:00 PM ET

Français
jeudi le 7 octobre 2021
19h00 á 21h00 HNE

CLICK HERE for more information and to register.

With the continued uncertainty related to the COVID-19 pandemic, Diabetes Canada, CSEM, and the National Planning Committee have collectively decided to offer the 2021 Professional Conference as a virtual experience from November 23–26, 2021.

Registration is now open, click here!

Abstract submission is now open!

• Abstracts for the CSEM general endocrinology and metabolism program are now being accepted for the 2021 Diabetes Canada/CSEM Professional Conference. Submissions are accepted from researchers, endocrinologists and trainees. Submit within the next week to take advantage of the early bird rate for $25.00 per abstract until Wednesday, May 19, 2021, 5:00 PM EDT. After May 19, the regular fee will be $45.00. Abstract submission closes on Wednesday, June 2, 2021, 11:59 PM EDT. Click here to submit a general abstract.
• CSEM is now accepting abstracts for resident clinical vignettes or proposed/in-progress basic science or translational research projects. Oral presentations and e-posters will be pre-recorded and presented virtually during the 2021 Diabetes Canada/CSEM Professional Conference. Submission deadline: Monday, September 6, 2021 at 11:59 PM EDT. Click here to submit a resident clinical vignette or proposed research project abstract.

The conference website will be updated as more information becomes available.

CSEM has received questions from its members regarding the eligibility and safety of the COVID-19 vaccines and patients with endocrine conditions. Health Canada recommendations are changing rapidly. Recognizing there is little data to address groups excluded in the vaccine trials, a risk benefit assessment will need to be case-by-case and in consideration of national, provincial and local regulations.

CSEM supports equitable access to COVID-19 vaccines for individuals with endocrine conditions. Patients with type 1 diabetes, other autoimmune conditions, and immunocompromised health should have a risk/benefit discussion with their health care provider to make an informed decision. Some patients have multiple comorbidities that affect their vaccine status and patients may need to discuss with the relevant specialist(s).

Please see our statement for resources and references, including Diabetes Canada's statement.

View the CSEM 2020 Annual Report here.

Renew Your Membership

Your CSEM membership expires January 15, 2021. Don't miss out on important updates and stay connected with your colleagues. Renew online now.

Not only do CSEM members get discounts at the Diabetes Canada/CSEM Professional Conference and other meetings, your membership also allows you to:

• contribute and collaborate with a network of endocrinologists across Canada;
• build your career potential through a united community;
• vote and take part in CSEM committees and leadership roles;
• stay connected and informed about the latest in endocrinology and metabolism, educational opportunities and events.

CSEM values your membership. It is only through a strong and engaged member base that we can effectively advocate for excellence in endocrinology research, education, and patient care, and advance the discipline of endocrinology and metabolism in Canada.